Identification of 1,2-dihydroquinazolin-2-ones kinase inhibitors as anti-coronavirus agents.
The growing threat of viral pandemics, along with the emergence and re-emergence of various viruses, highlights an urgent need for innovative antiviral strategies. Traditional antivirals typically target viral proteins, but this approach often faces challenges like drug resistance and specificity. In contrast, host-bas...